Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning ...

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

All 15-year-old children in the UK should be offered the vaccine against meningitis B (MenB) in the wake of fatal outbreaks ...

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...

Just a few months after it was formed by a merger of two psychedelic drug developers, AtaiBeckley has been snapped up by Eli ...

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on its blockbuster immunology drug Enbrel. In a move viewed as a test of states' ability ...

For decades, pharmaceutical marketing has been built on a simple premise: if we present the right data, to the right audience ...

The European Commission has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, making it the first oral ...

The steady stream of biotechs aiming to list on the Nasdaq has continued, with Attovia Therapeutics and Braveheart Bio the ...

Any uncertainty about whether the second Trump administration would prioritise healthcare fraud enforcement was put to rest ...

A national newborn screening programme for spinal muscular atrophy (SMA) will be rolled out in England, to give babies the ...